MAPK3 and colorectal cancer: Another study showed GPR44 expression and signaling in colorectal cancer tissue triggered proliferation, p-ERK1/2 and vascular endothelial growth factor (VEGF) expression and release, and increased metastatic activity, which could be used as a therapeutic target in colorectal cancer progression [40].